Bone growth proteins (XOMA)

N/A

Report date: 2022/02/18 14:04:29

Base Information

Drug NameBone growth proteins (XOMA)

Drug Alias Namedibotermin alfaOP-1

ClassificationBiologics > Protein drugs > Recombinant protein

Mechanisms of ActionBone morphogenetic protein receptor type-2 agonists

TargetsBone morphogenetic protein receptor type-2

Therapy Area/IndicationsOsteoporosisBone Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesXoma Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesXoma Corp

Active IndicationsN/A

Inactive IndicationsOsteoporosisBone Diseases

ATC CodeN/A